Swiss National Bank »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Swiss National Bank

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 79k 24.99
2024-06-30 $1.5M 79k 18.67

More positions owned by Swiss National Bank

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)

View all positions for Swiss National Bank

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
BlackRock
Fairmount Funds Management
Braidwell
Baker Bros. Advisors
Rubric Capital Management
Morgan Stanley
Hillhouse Capital Advisors
State Street Corporation
Pictet Asset Management Holding SA
Nuveen Asset Management
Dimensional Fund Advisors
Driehaus Capital Management
Rice Hall James & Associates
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A